DESCRIPTION
The authors report a case of a 47-year-old female with a history of sarcoidosis and early stage breast cancer diagnosed and treated for potential cure 10 years earlier with right mastectomy, who presented with a progressive left visual fi eld defect developing over 2 weeks. Physical examination demonstrated a lobulated choroidal mass with a serous retinal detachment ( fi gure 1 ). MRI confi rmed a left orbital retinal detachment. F-18 fl urodeoxyglucose (FDG) positron emission tomography CT (PET-CT) imaging demonstrated hypermetabolism diffusely throughout osseous structures, numerous lymph node stations and the left posterior choroid ( fi gures 2 and 3 ). No calcifi ed lymph nodes were seen on CT. Retrospective review of the MRI showed very mild enhancement correlating to the hypermetabolic choroid lesion. Biopsy of a hypermetabolic neck lymph node confi rmed the presence of metastatic breast cancer. Metastatic carcinoma to the eye is regarded as the most common intraocular malignant neoplasm, which in woman is breast cancer. 1 Metastatic deposits to the eye can spread to the choroid, optic disc, iris and ciliary body. Choroid tumours are one of the causes of serous retinal detachments, whereby subretinal fl uid produces localised exudative or bullous detachments of the retina. Malignant retinal detachments are an unusual clinical presentation of metastatic disease. 1 Retinal detachments are relatively uncommon affecting only 1 in 10 000 per year. 2 Most retinal detachments are rhegmatogenous in origin, a non-malignant condition which occurs when liquid vitreous enters the subretinal space through a retinal defect, creating a dissection plane between the retina and retinal epithelium. 2 The most common risk factors for rhegmatogenous retinal detachments include aging, cataract surgery, trauma and myopia. 1 Ocular sarcoid typically causes anterior uveitis, although posterior choroidal granulomas may occur with associated retinal detachments mimicking malignant detachments. 1 Although sarcoid-related retinal detachment is a consideration in this case, the constellation of fi ndings to include widespread metastatic disease with osseous involvement and lymph node biopsy results of metastatic breast carcinoma strongly favours a malignant aetiology. There is little data on specifi c MRI or PET-CT fi ndings in ocular sarcoid as the majority of cases are confi rmed by a combination of physical examination fi ndings, laboratory abnormalities such as elevated ACE levels, imaging fi ndings such as bilateral hilar lymphadenopathy on chest imaging, and compatible biopsy results. 3 Several case reports and a small number of studies have confi rmed the utility of PET-CT in evaluating ocular metastases. 4 5 FDG is typically taken up at site of the choroidal metastatic lesion. Differentiating benign from metastatic causes of retinal detachment profoundly alters management in patients with known prior malignancy, as external beam radiation treatment may preserve vision. PET-CT can aid in diagnosis.
Learning points
▶ PET-CT is a useful adjunct in the diagnostic imaging armamentarium in patients with suspected ocular metastatic disease. Metastatic lesions can cause retinal detachments and ▶ should be suspected in the appropriate clinical setting.
Figure 3
Whole body F-18 fl urodeoxyglucose positron emission tomography maximum intensity projection image demonstrates widespread hypermetabolic metastatic lesions throughout the neck, mediastinum, abdomen, as well as the axial and appendicular skeleton.
